Biocon puts cancer drug program on hold; TransCelerate hits milestone on trial initiative;

@FierceBiotech: Report: Seattle biotech VLST unloads assets and shuts doors. More | Follow @FierceBiotech

@JohnCFierce: Acceleron pitches $75M IPO as Celgene pushes partnership through PhII. News | Follow @JohnCFierce

@RyanMFierce: Now that "microbiome" means something to people... NuMe Health changes name to MicroBiome Therapeutics. Release | Follow @RyanMFierce

@EmilyMFierce: The Smithsonian plans to create a huge bank of genetic samples to enable large-scale genome sequencing. More | Follow @EmilyMFierce

> India's Biocon says that it has put a preclinical cancer program on hold after running into some patent issues. Story

> TransCelerate BioPharma reached its primary milestone in its Clinical Trial Comparator Network Initiative. Release

> Cyprotex, a U.K. drug testing company, says it is ready to expand after raising close to $11 million. Story

Medical Device News

@FierceMedDev: Navidea's losses widen as it waits for Lymphoseek to catch on. Article | Follow @FierceMedDev

@DamianFierce: Israel's Given Imaging had a record Q2 and believes better things are on the horizon. Report | Follow @DamianFierce

> Gene By Gene grabs GE-backed diagnostics startup. More

> Roche Dx cuts more diabetes jobs amid faltering sales. Report

> Medtronic implant could point to future of Parkinson's treatment. Story

Pharma News

@FiercePharma: Looking for a sales job? Lundbeck to hire > 200 to market antidepressant Brintellix, in prep for FDA nod. More | Follow @FiercePharma

@CarlyHFierce: In Vivus earnings, not a lot of revenue, but analysts seem optimistic about Zook's plans for Qsymia. Release | Follow @CarlyHFierce

> Novartis' ambitions for Afinitor suffer on liver-cancer failure. More

> Valeant CEO: Merger of equals still on the table. Story

> China revokes patent on Gilead's Viread. Article

Biomarkers News

> Biomarker IDs cancer patients most likely to respond to EGFR inhibitors. Item

> NIH pushes for biomarker research to catch up with needs of kids. Story

> Are cancer biomarker tests grossly underused? More

> Elevated carbon monoxide levels in breath can point to infection. Story

> Broad, Dana-Farber license lung cancer biomarker IP to MolecularMD. Article

> Altered enzyme indicates Alzheimer's-like dementia. Item

Drug Delivery News

@MichaelGFierce: 'Soft robotic' hydrogel arms show drug delivering capability. More | Follow @MichaelGFierce

> UCSD surgeons deliver cancer drugs to brain with ClearPoint MRI tech. Story

> 3M sells dry powder inhaler rights to Adamis. News

> Next-gen Alzheimer's drug targets brain enzyme. Story

> Ocular Therapeutix nets FDA panel meeting for eye surgery hydrogel. Item

> Halozyme regrouping after ViroPharma trial flop. Article

And Finally... In an effort to advance drug and disease research in children, a unit of the National Institutes of Health aims to fund studies of biomarkers of adult ailments for use in pediatric patients. Story

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.